Global Life Sciences Venture Capital Investor (excluding Asia)

SPOTLIGHT ON PIVOTAL U.S.

APPROACH + STRATEGY

Our life sciences venture capital investment team in the U.S.

We are a venture capital fund investing in privately held North American and European companies seeking companies with innovative therapeutic products and platforms that address major, unmet medical needs.

Life
Sciences

WHAT WE DO

We back the brightest minds in life sciences.

Our seasoned investment team brings over 50 years combined biotech venture capital and company building experience from top tier funds including Novo Ventures, TPG Biotech, Bay City Capital, NEA, and SV Life Sciences. We strive to leverage this extended network and expertise in evaluating new investment opportunities, building value in our portfolio, and in contributing management talent and referrals to our companies. We invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. We are capable of leading or co-leading transactions, and employ a rigorous investment review process that distinguishes us and helps us with syndicate building and positioning companies well for a future public offering or M&A event.   
Meet Our Pivotal U.S. Team

Investments

Our portfolio of holdings and Investments

COMPANY

Akouos Inc

COMPANY

Aligos Therapeutics Inc

COMPANY

Arcutis Biotherapeutics Inc

COMPANY

Avalyn Pharma Inc

COMPANY

Bolt Biotherapeutics

COMPANY

Evommune

COMPANY

Exscientia

COMPANY

Fusion Pharmaceuticals Inc

COMPANY

HotSpot Therapeutics

COMPANY

Inozyme Pharma Inc

COMPANY

Iterum Therapeutics Limited

COMPANY

Karuna Therapeutics Inc

COMPANY

Obsidian

COMPANY

Oculis SA

COMPANY

Plexium Inc

COMPANY

RallyBio Holdings LLC

COMPANY

Vaxcyte Inc

COMPANY

Vigil Neuroscience

CONTACT

Pivotal bioVenture Partners (US)

501 2nd Street, Suite 200
San Francisco, CA 94107